Synopsis
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Episodes
-
Treatment Goals and Targeted Therapies in Myasthenia Gravis
12/08/2024 Duration: 31minAre you up to date on the most recent clinical guidelines and treatment options for myasthenia gravis (MG)? Credit available for this activity expires: 8/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001404?ecd=bdc_podcast_libsyn_mscpedu
-
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway
05/08/2024 Duration: 37minHow can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_mscpedu
-
Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care
31/07/2024 Duration: 38minLearn from the experts about aligning treatments with patient expectations at first relapse of diffuse large B-cell lymphoma (DLBCL). Credit available for this activity expires: 7/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001321?ecd=bdc_podcast_libsyn_mscpedu
-
Incorporating Lipoprotein(a) Routinely Into Cardiovascular Risk Assessment: Why, What, Who, How, and When?
25/07/2024 Duration: 18minLearn from the experts about typical clinical scenarios, guidelines, and practical tips about lipoprotein(a) [Lp(a)]. Credit available for this activity expires: 7/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001247?ecd=bdc_podcast_libsyn_mscpedu
-
Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today
17/07/2024 Duration: 29minClinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date? Credit available for this activity expires: 7/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu
-
Exploring the Value of Delivering Lung Cancer Medicines in Different Ways: Optimizing the Patient Experience
12/07/2024 Duration: 41minNew subcutaneous (SC) therapies are becoming available in lung cancer. Are you ready to talk to your patients about these? Credit available for this activity expires: 7/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001272?ecd=bdc_podcast_libsyn_mscpedu
-
Latest Advances in Breast Cancer Care: Highlights From Chicago 2024
11/07/2024 Duration: 16minMissed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire program was made for you! Credit available for this activity expires: 7/9/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001283?ecd=bdc_podcast_libsyn_mscpedu
-
Obesity Care: Improving Health Outcomes in Collaboration With the Patient
28/06/2024 Duration: 35minWhat impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them? Credit available for this activity expires: 06/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001269?ecd=bdc_podcast_libsyn_mscpedu
-
The Evolution of Incretins – A Revolution in Diabetes Management?
27/06/2024 Duration: 35minThe expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice? Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu
-
Dengue: A Leading Cause of Travel-Related Fever – Vaccinating Travelers to Endemic Regions
26/06/2024 Duration: 20minAre you up to date on the risk for dengue and how to implement dengue vaccination in travelers to endemic regions? Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001216?ecd=bdc_podcast_libsyn_mscpedu
-
Unlocking the Power of Tumor-Agnostic Therapy: A Path to Personalized Cancer Care
24/06/2024 Duration: 36minAre you aware of the currently approved tumor-agnostic drugs? Listen to the experts as they discuss them. Credit available for this activity expires: 06/21/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001234?ecd=bdc_podcast_libsyn_mscpedu
-
Multiple Sclerosis Biosimilars in Europe: How to Communicate With Your Patient for Successful Implementation
12/06/2024 Duration: 20minDid you know that specific words and gestures you use can cause the nocebo effect? Credit available for this activity expires: 6/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000861?ecd=bdc_podcast_libsyn_mscpedu
-
A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD
07/06/2024 Duration: 31minAre you up to date on low-density lipoprotein cholesterol (LDL-C)–lowering therapy in high-risk patients? Credit available for this activity expires: 06/06/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000828?ecd=bdc_podcast_libsyn_mscpedu
-
Antibody-Drug Conjugates in the Spotlight: Novel Strategies for Breast Cancer Management
31/05/2024 Duration: 37minAre you up to date on the key clinical data on ADCs in breast cancer -- especially those that set the stage for upcoming data releases? Credit available for this activity expires: 5/31/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000851?ecd=bdc_podcast_libsyn_mscpedu
-
Decoding Epilepsy Treatment Strategies: A Case-Based Exploration
31/05/2024 Duration: 20minCombining data, guidelines, and experience to select appropriate treatments for individuals with focal epilepsy. Credit available for this activity expires: 5/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000865?ecd=bdc_podcast_libsyn_mscpedu
-
Delivering Precision Oncology to Patients: From Principles to Practice
31/05/2024 Duration: 31minHow can molecular profiling guide cancer therapy? Join our experts to learn how to best utilize molecular testing in clinical practice. Credit available for this activity expires: 5/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001132?ecd=bdc_podcast_libsyn_mscpedu
-
Chronic Inflammatory Demyelinating Polyneuropathy: How Insights From Disease Biology Inform Novel Therapies
31/05/2024 Duration: 32minDid you know that more than 20% of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) do not respond to current first-line treatments? Credit available for this activity expires: 5/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000839?ecd=bdc_podcast_libsyn_mscpedu
-
Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice
30/05/2024 Duration: 34minWhat are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey. Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn_mscpedu
-
Evolving Perspectives on HR-Positive Metastatic Breast Cancer: Current Understanding and New Insights
21/05/2024 Duration: 34minAre you up to date on the latest developments in hormone receptor-positive metastatic breast cancer? Listen to our expert panel to find out more! Credit available for this activity expires: 05/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000713?ecd=bdc_podcast_libsyn_mscpedu
-
SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question
13/05/2024 Duration: 28minAre you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)? Credit available for this activity expires: 5/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu